Accelerating Drug Discovery
Information technology is revolutionizing drug discovery and development, enhancing conventional searches for the best compounds and molecules with computer-aided decision-making support. In silico experiments have become natural for modern pharmaceutical and biotech companies, allowing them to conduct research faster and at a lower cost, thereby reducing the number of in vitro tests and sending only the most promising drug candidates to preclinical and clinical research. This becomes possible with emerging technology solutions that are reshaping the research landscape by bringing in artificial intelligence software, utilizing big data and data visualization and analytics to facilitate and accelerate the discovery process.
With each client’s unique needs in mind, DataArt collaborates with laboratories, pharma and biotech companies to help develop best-in-class custom software such as research tools, lab automation and workflow management systems aimed at streamlining drug discovery and development processes.